Spry2 regulates signalling dynamics and terminal bud branching behaviour during lung development

Area of Science:

• Developmental Biology
• Molecular Biology
• Genetics

Background:

• Mammalian lung development relies on coordinated epithelial branching driven by reciprocal cell signaling.
• Key signaling pathways involved include FGF, SHH, and BMP4.

Purpose of the Study:

• To investigate the role of Spry2, an antagonist of FGF signaling, in mammalian lung development.
• To characterize lung defects in Spry2-deficient mice and understand the underlying molecular mechanisms.

Main Methods:

• Analysis of lung defects in 36Pub mice with a Spry2 deletion.
• Genetic complementation studies using targeted Spry2 disruption and Spry2-BAC transgenes.
• Examination of gene expression patterns (Fgf10, Shh, Bmp4) in Spry2-deficient lungs.

Main Results:

• Spry2 deficiency leads to enlarged cystic structures at the lung lobe termini.
• Reduced lung branching and early formation of cystic structures were observed.
• Loss of Spry2 altered the expression and spatial organization of Fgf10, Shh, and Bmp4, indicating a disrupted signaling balance.

Conclusions:

• Spry2 is essential for regulating lung branching and preventing cystic malformations.
• Altered signaling balance due to Spry2 loss delays branching and promotes cystic growth.
• The study emphasizes the importance of controlled cellular responsiveness to signaling and the interplay of morphogenesis with gene expression localization.